Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Schwartzentruber

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Current Opinion in Oncology|November 1, 1993
In vitro predictors of clinical response in patients receiving interleukin-2-based immunotherapyD J Schwartzentruber
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 22, 2001
Guidelines for the safe administration of high-dose interleukin-2D J Schwartzentruber
Cancer Journal (Sudbury, Mass.)|April 28, 2001
High-dose interleukin-2 is an intensive treatment regardless of the venue of administrationD J Schwartzentruber
Journal of Clinical Gastroenterology|July 1, 1995
Evolving strategies for the treatment of adenocarcinoma of the pancreas. A reviewS E Ettinghausen, D J Schwartzentruber, W F Sindelar
Magnetic Resonance Imaging|January 1, 1987
Ingested manganese chloride as a contrast agent for magnetic resonance imagingD A Cory, D J Schwartzentruber, B H Mock
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|July 1, 1992
Characterization of lymphocytes infiltrating human breast cancer: specific immune reactivity detected by measuring cytokine secretionD J Schwartzentruber, D Solomon, S A Rosenberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1991
Specific release of granulocyte-macrophage colony-stimulating factor, tumor necrosis factor-alpha, and IFN-gamma by human tumor-infiltrating lymphocytes after autologous tumor stimulationD J Schwartzentruber, S L Topalian, M Mancini, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1995
CD4+ T lymphocytes infiltrating human breast cancer recognise autologous tumor in an MHC-class-II restricted fashionR Dadmarz, M K Sgagias, S A Rosenberg, et al.
Blood|August 15, 1993
Tumor-infiltrating lymphocytes derived from select B-cell lymphomas secrete granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha in response to autologous tumor stimulationD J Schwartzentruber, M Stetler-Stevenson, S A Rosenberg, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|January 1, 1993
Specific release of cytokines by lymphocytes infiltrating human melanomas in response to shared melanoma antigensS S Hom, D J Schwartzentruber, S A Rosenberg, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Current Opinion in Oncology|November 1, 1993
In vitro predictors of clinical response in patients receiving interleukin-2-based immunotherapyD J Schwartzentruber
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 22, 2001
Guidelines for the safe administration of high-dose interleukin-2D J Schwartzentruber
Cancer Journal (Sudbury, Mass.)|April 28, 2001
High-dose interleukin-2 is an intensive treatment regardless of the venue of administrationD J Schwartzentruber
Journal of Clinical Gastroenterology|July 1, 1995
Evolving strategies for the treatment of adenocarcinoma of the pancreas. A reviewS E Ettinghausen, D J Schwartzentruber, W F Sindelar
Magnetic Resonance Imaging|January 1, 1987
Ingested manganese chloride as a contrast agent for magnetic resonance imagingD A Cory, D J Schwartzentruber, B H Mock
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|July 1, 1992
Characterization of lymphocytes infiltrating human breast cancer: specific immune reactivity detected by measuring cytokine secretionD J Schwartzentruber, D Solomon, S A Rosenberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1991
Specific release of granulocyte-macrophage colony-stimulating factor, tumor necrosis factor-alpha, and IFN-gamma by human tumor-infiltrating lymphocytes after autologous tumor stimulationD J Schwartzentruber, S L Topalian, M Mancini, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1995
CD4+ T lymphocytes infiltrating human breast cancer recognise autologous tumor in an MHC-class-II restricted fashionR Dadmarz, M K Sgagias, S A Rosenberg, et al.
Blood|August 15, 1993
Tumor-infiltrating lymphocytes derived from select B-cell lymphomas secrete granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha in response to autologous tumor stimulationD J Schwartzentruber, M Stetler-Stevenson, S A Rosenberg, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|January 1, 1993
Specific release of cytokines by lymphocytes infiltrating human melanomas in response to shared melanoma antigensS S Hom, D J Schwartzentruber, S A Rosenberg, et al.
Pageof 5